• J Stroke Cerebrovasc Dis · Feb 2015

    Gaps and hurdles deter against following stroke guidelines for thrombolytic therapy in Iran: exploring the problem.

    • Karim Nikkhah, Abolfazl Avan, Ali Shoeibi, Amir Azarpazhooh, Kavian Ghandehari, Christian Foerch, Gustavo Saposnik, Payam Sasannejad, Veda Vakili, Parvaneh Layegh, Mohammad Taghi Farzadfard, Bavarsad ShahripourRezaRComprehensive Stroke Center, Department of Neurology, University of Alabama, Birmingham, Alabama., Mohammad Reza Hosseini, and Mahmoud Reza Azarpazhooh.
    • Department of Neurology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
    • J Stroke Cerebrovasc Dis. 2015 Feb 1; 24 (2): 408-15.

    BackgroundInsufficient information is available on the barriers that explain low rates of thrombolytic therapy for acute ischemic stroke (AIS) in developing countries compared with rates in developed societies. By the present study, we aimed to assess the implementation of thrombolytic therapy in the northeast of Iran to explore the gaps and hurdles against thrombolysis as the generally accepted treatment for AIS.MethodsIn a 1-year cohort study among AIS patients admitted to the second largest tertiary neurologic referral center in Iran, those who met the prespecified selection criteria were treated with intravenous recombinant tissue plasminogen activator (rtPA).ResultsAmong 1,144 patients admitted with AIS, only 14 (1.2%) were treated with rtPA. The mean onset-to-needle and door-to-needle times were 172 and 58 minutes, respectively; 980 (85.6%) patients were initially excluded from the study because of late arrival. Additionally, 60 patients in total were omitted because of either their high age (3.7%) or passing the gold standard time limit for rtPA therapy after preliminary evaluations (1.6%), and 90 more patients (7.9%) were considered not suitable for thrombolysis because of the severity of the symptoms or the higher risk of bleeding on rtPA.ConclusionsAccess to thrombolytic therapy for AIS in Iran is less than in most developed countries but comparable with other developing countries. Awareness campaigns are needed to minimize barriers and improve access to thrombolysis and specialized stroke care in Iran.Copyright © 2015 National Stroke Association. Published by Elsevier Inc. All rights reserved.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…